` MEM (Memphasys Ltd) vs S&P/ASX 300 Comparison - Alpha Spread

M
MEM
vs
S
S&P/ASX 300

Over the past 12 months, MEM has underperformed S&P/ASX 300, delivering a return of -17% compared to the S&P/ASX 300's +6% growth.

Stocks Performance
MEM vs S&P/ASX 300

Loading
MEM
S&P/ASX 300
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
MEM vs S&P/ASX 300

Performance Gap Between MEM and AXKO
HIDDEN
Show

Performance By Year
MEM vs S&P/ASX 300

Loading
MEM
S&P/ASX 300
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Memphasys Ltd vs Peers

S&P/ASX 300
MEM
0KHE
TMO
DHR
LONN
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Memphasys Ltd
Glance View

Memphasys Ltd. is a life sciences company. The company is headquartered in Homebush West, New South Wales. The company went IPO on 2007-05-14. The company develops medical devices, diagnostics and media with application to assists reproduction technologies in humans and animals. The Company’s lead product is Felix device. The Felix is an automated device for separating quality sperm from a semen sample for the use in human in vitro fertilization (IVF) procedures. The firm's membrane technology utilizes its separation technology along with its multiple devices and hydrogel membranes to fractionate biological molecules. The technology relies on the applied electric field and charged biological molecules. The sample and harvest chamber are formed by placing the separation membrane in between two restriction membranes with restricted pores.

MEM Intrinsic Value
HIDDEN
Show
Back to Top